Malignant pleural effusion: medical approaches for diagnosis and management. 2014

Hae-Seong Nam
Center for Lung Cancer and Division of Pulmonary, Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.

Malignant pleural effusions (MPEs) are the second leading cause of exudative pleural effusions after parapneumonic effusions. In the vast majority of cases, a MPE signifies incurable disease associated with high morbidity and mortality. Considerable advances have been made for the diagnosis of MPEs, through the development of improved methods in the specialized cytological and imaging studies. The cytological or histological confirmation of malignant cells is currently important in establishing a diagnosis. Furthermore, despite major advancements in cancer treatment for the past two decades, management of MPE remains palliative. This article presents a comprehensive review of the medical approaches for diagnosis and management of MPE.

UI MeSH Term Description Entries

Related Publications

Hae-Seong Nam
October 2006, Lung cancer (Amsterdam, Netherlands),
Hae-Seong Nam
January 2020, Canadian respiratory journal,
Hae-Seong Nam
April 1993, Cancer treatment reviews,
Hae-Seong Nam
October 2022, The American journal of medicine,
Hae-Seong Nam
January 2021, Archivos de bronconeumologia,
Hae-Seong Nam
January 2003, Pneumonologia i alergologia polska,
Copied contents to your clipboard!